Clinical Competency Assessment


As the pandemic has become a catalyst for change, the College has been considering opportunities and assessment models to support candidates in their progression to Fellowship and will be considering a broader change in the theories and practice of assessment as a long-term strategy for the RANZCP.

After considerable discussion and stakeholder consultation, the Board has approved the implementation of the Clinical Competency Assessment (CCA), as a continuation of the Alternative Assessment Pathway (AAP) with some modifications, for the delivery for the remainder of 2022, and 2023.

There will be no OSCEs offered in 2022-2023.

The assessment comprises a Portfolio Review of completed In-Training Assessments (ITAs), and if required, a Case-based Discussion held via Zoom.

Under the Clinical Competency Assessment (CCA) to be offered in 2022 and 2023:

  • All candidates are required to undergo a Portfolio Review.
  • Candidates who are not able to demonstrate the required competency and standard via the Portfolio Review, will proceed to a Case-based Discussion (CbD).

The major changes from the current AAP process are:

  • The Portfolio Review for trainees will require an assessment of their three (3) latest end-of-rotation ITAs, one of which must be a Stage 3 ITA of at least 6 months (FTE) duration. For SIMGs, there may be instances where only two end-of-rotation ITAs may be considered (as per the current Portfolio Review rules).
  • Written case summaries will be assessed as part of the Communication domain of the CbD marking guide, and candidates will submit these if/when required.

The CCA will NOT be a ‘No-Disadvantage Exam’ - the results from this assessment will be reflected in the candidates’ training trajectory.


Results are published on the results, timetables fees page. Individual result letters are made available on InTrain.


Have you found the information you were looking for?